August 27, 2020

Prostate Cancer is the second most common cancer diagnosed in men worldwide. (1) Prostate Cancer treatment options  Various management options are available including surgery, radiation, and medications. Shared-decision making between healthcare providers and patients is key to choosing a prostate cancer management plan that helps promote patient satisfaction and the patient’s desired quality of life....

Decreased Participation in Prostate Clinical Trials African Americans have the highest incidence of prostate cancer, yet their participation in clinical trials related to prostate cancer is low.  The inclusion of African American men in prostate cancer trials has decreased from 11.3% in 1995 to 2.8% in 2014. (1)   Lab Miscalculation  A study reviewed a...

Focal segmental glomerulosclerosis (FSGS) is the leading glomerular cause of  nephrotic syndrome among African Americans and is typically associated with edema, proteinuria, hypertension, microscopic hematuria, and renal insufficiency. MD Newsline recently interviewed nephrologist Dr. Frita Mcrae about FSGS and kidney disease in Black patient populations. MD Newsline: Dr. Frita, in regard to FSGS why is...

In the united states, there will be approximately 192,000 cases of prostate cancer in 2020 and 33,000 deaths. 1 Clinical trials are often sought in advanced cases of cancer when standard therapy is not working or not an option. Clinical trials have the benefit of providing patients with access to therapies not routinely available. Immunotherapy...